These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27617404)

  • 21. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
    Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
    J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecular basis for neurofibroma-associated skeletal manifestations in NF1.
    Ma Y; Gross AM; Dombi E; Pemov A; Choi K; Chaney K; Rhodes SD; Angus SP; Sciaky N; Clapp DW; Ratner N; Widemann BC; Rios JJ; Elefteriou F
    Genet Med; 2020 Nov; 22(11):1786-1793. PubMed ID: 32601387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How does the Schwann cell lineage form tumors in NF1?
    Carroll SL; Ratner N
    Glia; 2008 Nov; 56(14):1590-1605. PubMed ID: 18803326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term culture and characterization of human neurofibroma-derived Schwann cells.
    Rosenbaum T; Rosenbaum C; Winner U; Müller HW; Lenard HG; Hanemann CO
    J Neurosci Res; 2000 Sep; 61(5):524-32. PubMed ID: 10956422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells.
    Staser K; Yang FC; Clapp DW
    Curr Opin Hematol; 2010 Jul; 17(4):287-93. PubMed ID: 20571392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Schwann cell dedifferentiation originate dermal neurofibromas?
    Iribar H; Jaka A; Ormaechea N; Tuneu A; Izeta A; Gutiérrez-Rivera A
    Exp Dermatol; 2016 Nov; 25(11):901-903. PubMed ID: 27303947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
    Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
    J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1
    Pennanen P; Peltonen S; Kallionpää RA; Peltonen J
    Mol Cell Biochem; 2018 Jul; 444(1-2):27-33. PubMed ID: 29185159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
    Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
    Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoamide Inhibits NF1 Deficiency-induced Epithelial-Mesenchymal Transition in Murine Schwann Cells.
    Zhang Y; Zhou R; Qu Y; Shu M; Guo S; Bai Z
    Arch Med Res; 2017 Aug; 48(6):498-505. PubMed ID: 29198560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights into the neurofibroma tumor cells of origin.
    Li S; Chen Z; Le LQ
    Neurooncol Adv; 2020 Jul; 2(Suppl 1):i13-i22. PubMed ID: 32642729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of nerve microenvironment for neurofibroma development.
    Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
    Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
    Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF
    Science; 2002 May; 296(5569):920-2. PubMed ID: 11988578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells.
    Kawachi Y; Maruyama H; Ishitsuka Y; Fujisawa Y; Furuta J; Nakamura Y; Ichikawa E; Furumura M; Otsuka F
    Exp Dermatol; 2013 Apr; 22(4):262-5. PubMed ID: 23528211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
    Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
    Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.
    Rhodes SD; He Y; Smith A; Jiang L; Lu Q; Mund J; Li X; Bessler W; Qian S; Dyer W; Sandusky GE; Horvai AE; Armstrong AE; Clapp DW
    Hum Mol Genet; 2019 Aug; 28(16):2752-2762. PubMed ID: 31091306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
    Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
    Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
    Yang FC; Ingram DA; Chen S; Zhu Y; Yuan J; Li X; Yang X; Knowles S; Horn W; Li Y; Zhang S; Yang Y; Vakili ST; Yu M; Burns D; Robertson K; Hutchins G; Parada LF; Clapp DW
    Cell; 2008 Oct; 135(3):437-48. PubMed ID: 18984156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Plexiform Neurofibroma Cells at Doses That Do Not Affect Patient-Matched Schwann Cells.
    Attiah B; Alewine G; Easter MK; Coover RA; Fahrenholtz CD
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening.
    Kraniak JM; Chalasani A; Wallace MR; Mattingly RR
    Exp Neurol; 2018 Jan; 299(Pt B):289-298. PubMed ID: 29055717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.